Invention Grant
US08802240B2 Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
有权
甲状腺激素类似物及其纳米颗粒形式的制剂的使用以增加肿瘤或癌细胞中的化学敏感性和放射敏感性
- Patent Title: Uses of formulations of thyroid hormone analogs and nanoparticulate forms thereof to increase chemosensitivity and radiosensitivity in tumor or cancer cells
- Patent Title (中): 甲状腺激素类似物及其纳米颗粒形式的制剂的使用以增加肿瘤或癌细胞中的化学敏感性和放射敏感性
-
Application No.: US13345194Application Date: 2012-01-06
-
Publication No.: US08802240B2Publication Date: 2014-08-12
- Inventor: Paul J. Davis , Shaker A. Mousa
- Applicant: Paul J. Davis , Shaker A. Mousa
- Applicant Address: US NY Rensselaer
- Assignee: Nanopharmaceuticals LLC
- Current Assignee: Nanopharmaceuticals LLC
- Current Assignee Address: US NY Rensselaer
- Agency: Schmeiser, Olsen & Watts, LLP
- Main IPC: A61K31/198
- IPC: A61K31/198 ; A61K31/192 ; A61K31/704 ; A61P29/00
Abstract:
Disclosed are methods of increasing the chemosensitivity of normal and/or chemoresistant tumor or cancer cells using thyroid hormone analogs and/or nanoparticulate or polymeric forms thereof. Also disclosed are methods of increasing radiosensitivity of normal and/or radioresistant tumor or cancer cells using thyroid hormone analogs and/or nanoparticulate or polymeric forms thereof.
Public/Granted literature
Information query
IPC分类:
